Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oumar Diouf"'
Autor:
Meng Fen Wu, Tara Gray, John Hicks, Oumar Diouf, Zhongzhen Yi, Stephen Gottschalk, Meenakshi Hegde, Catherine Robertson, Vita S. Brawley, Claudia Gerken, Amanda Wakefield, Helen E. Heslop, Pamela New, Hao Liu, Mamta Kalra, Yvonne Kew, Winfried S. Wels, Robert G. Grossman, Milica Stojakovic, Alexia Ghazi, Kevin Bielamowicz, Aidin Ashoori, David S. Baskin, Cliona M. Rooney, Gianpietro Dotti, Yi Jonathan Zhang, Suzanne Zein-Eldin Powell, Nabil Ahmed, Adrian P. Gee, Bambi Grilley, Malcolm K. Brenner, Jack Su, Daniel Landi
Glioblastoma is an incurable tumor, and the therapeutic options for patients are limited. To determine whether the systemic administration of HER2-specific chimeric antigen receptor (CAR)-modified virus-specific T cells (VSTs) is safe and whether the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7c2c0e930a946260a767da89b32c40
Autor:
Andrea M. Sheehan, Youli Zu, Elizabeth J. Shpall, Cliona M. Rooney, Barbara Pro, Stephanie Ku, Daniel Lee, George Carrum, Oumar Diouf, Malcolm K. Brenner, Meng Fen Wu, Hao Liu, Catherine M. Bollard, Adrian P. Gee, Luis Fayad, Stephen Gottschalk, Yasmin Hazrat, Carlos A. Ramos, Helen E. Heslop, Vicky Torrano
Publikováno v:
Journal of Clinical Oncology. 32:798-808
Purpose Tumor cells from approximately 40% of patients with Hodgkin or non-Hodgkin lymphoma express the type II latency Epstein-Barr virus (EBV) antigens latent membrane protein 1 (LMP1) and LMP2, which represent attractive targets for immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5ea9ca917694cde007d16e505becd7b
https://doi.org/10.1200/jco.2013.51.5304
https://doi.org/10.1200/jco.2013.51.5304
Autor:
Mamta Kalra, Daniel Landi, David S. Baskin, Amanda Wakefield, Yzonne Kew, Oumar Diouf, John Hicks, Robert G. Grossman, Nabil Ahmed, Adrian P. Gee, Suzanne Zein-Eldin Powell, Meenakshi Hegde, Alexia Ghazi, Aidin Ashoori, Vita S. Brawley, Helen E. Heslop, Gianpietro Dotti, Pamela New, Winfried S. Wels, Claudia Gerken, Jonathan Zhang, Kevin Bielamowicz, Zhongzhen Yi, Stephen Gottschalk, Cliona M. Rooney
Publikováno v:
Journal for Immunotherapy of Cancer
Glioblastoma (GBM) remains incurable with current standard-of-care therapies. Adoptive T cell transfer holds the promise to improve outcomes for GBM patients. We report on the results of the Phase I clinical study, NCT01109095, administering autologo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6362afba4e45b72f4dd1da8f13c6e6e3
Autor:
Carlos A. Ramos, Adrian P. Gee, Minthran Ngo, Vicky Torrano, Lisa Rollins, Cliona M. Rooney, Catherine M. Bollard, Stephen Gottschalk, Jun Ando, Oumar Diouf, Natalia Lapteva, Helen E. Heslop, Ann M. Leen, Juan F. Vera, Serena K. Perna
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a005eb2174001348c8efdcb8b9b0be6c
Autor:
Zhuyong Mei, Enli Liu, Martin Pule, Heidi V. Russell, Hao Liu, Malcolm K. Brenner, G. Doug Myers, Claudia Rossig, Adrian P. Gee, Barbara Savoldo, Meng Fen Wu, Gianpietro Dotti, Eric Yvon, Helen E. Heslop, Oumar Diouf, Chrystal U. Louis, Cliona M. Rooney
We generated MHC-independent chimeric antigen receptors (CARs) directed to the GD2 antigen expressed by neuroblastoma tumor cells and treated patients with this disease. Two distinguishable forms of this CAR were expressed in EBV-specific cytotoxic T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64a54a3b4d82d34ad1cb0e2e6e8cdd7
https://europepmc.org/articles/PMC3234664/
https://europepmc.org/articles/PMC3234664/
Autor:
Renuka Miller, Serena Perna, Stephen Gottschalk, George Carrum, Carlos Ramos, Oumar Diouf, Mengfen Wu, Robert A. Krance, Adrian Gee, Malcolm K. Brenner, Cliona Rooney, Helen Heslop, Catherine Bollard
Publikováno v:
Cytotherapy. 17:S18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8427e06c21c21c23c220f44e3d96f326
https://doi.org/10.1016/j.jcyt.2015.03.362
https://doi.org/10.1016/j.jcyt.2015.03.362
Autor:
Adrian P. Gee, Joanna Yi, Jonathan Zhang, Robert G. Grossman, Amanda Wakefield, Aidin Ashoori, Suzanne Zein-Eldin Powell, Pamela New, Helen E. Heslop, Winfried S. Wels, Cliona M. Rooney, Vita Brawley, John Hicks, Yvonne Kew, Gianpietro Dotti, Hao Liu, Claudia Gerken, David S. Baskin, Malcolm K. Brenner, Alexia Ghazi, Nabil Ahmed, Stephen Gottschalk, Oumar Diouf
Publikováno v:
Molecular Therapy. 23:S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::524301607aabd724f9764a4ac93235cf
https://doi.org/10.1016/s1525-0016(16)33623-1
https://doi.org/10.1016/s1525-0016(16)33623-1
Autor:
Conrad Russell Y. Cruz, Kenneth P. Micklethwaite, Barbara Savoldo, Carlos A. Ramos, Sharon Lam, Stephanie Ku, Oumar Diouf, Enli Liu, A. John Barrett, Sawa Ito, Elizabeth J. Shpall, Robert A. Krance, Rammurti T. Kamble, George Carrum, Chitra M. Hosing, Adrian P. Gee, Zhuyong Mei, Bambi J. Grilley, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Catherine M. Bollard, Gianpietro Dotti
Publikováno v:
Blood. 122:152-152
Donor lymphocyte infusions (DLI) following hematopoietic stem cell transplantation may reduce or control opportunistic infections and leukemia/lymphoma relapse, but the associated graft versus host disease (GvHD) limits the clinical success of this p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c9e9a72a6943f494ee5dc028a0c84c
https://doi.org/10.1182/blood.v122.21.152.152
https://doi.org/10.1182/blood.v122.21.152.152
Autor:
Nabil Ahmed, Oumar Diouf, Peter M. Anderson, John Hicks, Gianpietro Dotti, Malcolm K. Brenner, Hao Liu, Adrian P. Gee, Cliona M. Rooney, Lisa Wang, Stephen Gottschalk, Vita S. Brawley, Helen E. Heslop, Winfried S. Wels
Publikováno v:
Cancer Research. 72:3500-3500
INTRODUCTION: The prognosis for patients with advanced osteosarcoma (OS) has not improved over the last two decades. Hence novel biologically-based therapies, such as immunotherapy, are needed for these patients. We have shown in preclinical studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::661ac864f6978480cb361b3a63fc7f6e
https://doi.org/10.1158/1538-7445.am2012-3500
https://doi.org/10.1158/1538-7445.am2012-3500
Autor:
Robert A. Krance, A. John Barrett, Cliona M. Rooney, Catherine M. Bollard, Conrad Russell Y. Cruz, Malcolm K. Brenner, Gianpietro Dotti, Oumar Diouf, Helen E. Heslop, Barbara Savoldo, Kenneth P. Micklethwaite, Stephanie Ku, Rammurti T. Kamble, Elizabeth J. Shpall
Publikováno v:
Blood. 118:4083-4083
Abstract 4083 Allogeneic hematopoietic stem cell transplant (HSCT) may increase long term disease free survival in patients with high risk B-cell malignancies. The delayed immune reconstitution associated with the procedure is, however, associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb2bc0f7298ea41b7c3db90db74f5e4
https://doi.org/10.1182/blood.v118.21.4083.4083
https://doi.org/10.1182/blood.v118.21.4083.4083